EMEA-001392-PIP01-12 - paediatric investigation plan

chlormethine

Key facts

• Active substance:
  chlormethine
• Therapeutic area:
  Oncology
• Decision number:
  P/0098/2013
• PIP number:
  EMEA-001392-PIP01-12
• Pharmaceutical form(s):
  Gel
• Condition(s) / indication(s):
  Treatment of Cutaneous T-Cell Lymphoma
• Route(s) of administration:
  Cutaneous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  29/04/2013
• Compliance check done:
  No

Decision

P/0098/2013: EMA decision of 29 April 2013 on the granting of a product-specific waiver for chlormethine (EMEA-001392-PIP01-12)

Adopted Reference Number: EMA/201938/2013